Schonfeld Strategic Advisors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-144,728
| Closed | -$1.87M | – | 2521 |
|
|
2025
Q4 | $1.87M | Buy |
144,728
+113,599
| +365% | +$1.46M | 0.01% | 899 |
|
|
2025
Q3 | $402K | Buy |
+31,129
| New | +$416K | ﹤0.01% | 1746 |
|
|
2025
Q1 | – | Sell |
-105,280
| Closed | -$3.14M | – | 2414 |
|
|
2024
Q4 | $3.14M | Buy |
+105,280
| New | +$2.23M | 0.02% | 660 |
|
|
2024
Q3 | – | Sell |
-101,140
| Closed | -$1.73M | – | 2296 |
|
|
2024
Q2 | $1.73M | Sell |
101,140
-262,637
| -72% | -$4.62M | 0.01% | 968 |
|
|
2024
Q1 | $5.69M | Buy |
363,777
+287,014
| +374% | +$4.22M | 0.04% | 596 |
|
|
2023
Q4 | $1.15M | Buy |
76,763
+28,113
| +58% | +$376K | 0.01% | 985 |
|
|
2023
Q3 | $786K | Buy |
+48,650
| New | +$1.4M | 0.01% | 1093 |
|
|
2023
Q1 | – | Sell |
-342
| Closed | -$25.1K | – | 2470 |
|
|
2022
Q4 | $25.1K | Buy |
+342
| New | +$25.7K | ﹤0.01% | 2306 |
|
|
2022
Q2 | – | Sell |
-11,300
| Closed | -$936K | – | 2859 |
|
|
2022
Q1 | $936K | Buy |
+11,300
| New | +$832K | 0.01% | 1029 |
|
|
2021
Q4 | – | Sell |
-1,812
| Closed | -$211K | – | 2410 |
|
|
2021
Q3 | $211K | Buy |
+1,812
| New | +$274K | ﹤0.01% | 1737 |
|
|
2020
Q4 | – | Sell |
-5,296
| Closed | -$589K | – | 1777 |
|
|
2020
Q3 | $589K | Buy |
+5,296
| New | +$423K | 0.01% | 863 |
|
|
2020
Q2 | – | Sell |
-14,674
| Closed | -$988K | – | 1459 |
|
|
2020
Q1 | $988K | Buy |
+14,674
| New | +$1.16M | 0.06% | 374 |
|
|
2019
Q4 | – | Sell |
-15,097
| Closed | -$1.13M | – | 1424 |
|
|
2019
Q3 | $1.13M | Buy |
+15,097
| New | +$1.21M | 0.03% | 445 |
|
Other funds holding NVCR
SCM
VPM
VCM
QCM